Halma (LON:HLMA) Earns Buy Rating from UBS Group

Halma (LON:HLMA)‘s stock had its “buy” rating reiterated by investment analysts at UBS Group in a note issued to investors on Friday,London Stock Exchange reports. They currently have a £47,750 price objective on the stock.

Separately, Shore Capital Group reiterated a “hold” rating on shares of Halma in a report on Monday, April 13th. Five research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of £5,338.78.

Halma Price Performance

Shares of HLMA opened at GBX 4,724 on Friday. The company has a market capitalization of £17.84 billion, a price-to-earnings ratio of 51.66, a P/E/G ratio of 2.93 and a beta of 0.96. Halma has a fifty-two week low of GBX 2,944 and a fifty-two week high of GBX 4,902. The company has a debt-to-equity ratio of 43.44, a current ratio of 2.18 and a quick ratio of 1.51. The business’s 50-day moving average is GBX 4,356.13 and its 200-day moving average is GBX 3,918.87.

About Halma

Halma is a global group of life-saving technology companies, focused on growing a safer, cleaner, healthier future for everyone, every day. Its purpose defines the three broad markets it operates in:

– Safety – Protecting people’s safety and the environment as populations grow, and enhancing worker safety.
– Environment – Addressing the impacts of climate change, pollution and waste, protecting life-critical resources and supporting scientific research.
– Health – Meeting the increasing demand for better healthcare as chronic illness rises, driven by growing and ageing populations and lifestyle changes.

Halma employs over 9,000 people in more than 20 countries, with major operations in the UK, Mainland Europe, the USA and Asia Pacific.